华西口腔医学杂志
華西口腔醫學雜誌
화서구강의학잡지
WEST CHINA JOURNAL OF STOMATOLOGY
2014年
5期
493-497
,共5页
杨晓喻%李世轶%张迪%吴颖%杨涛%刘长虹
楊曉喻%李世軼%張迪%吳穎%楊濤%劉長虹
양효유%리세질%장적%오영%양도%류장홍
人骨形态发生蛋白2%真核表达载体%壳聚糖%纳米复合体
人骨形態髮生蛋白2%真覈錶達載體%殼聚糖%納米複閤體
인골형태발생단백2%진핵표체재체%각취당%납미복합체
human bone morphogenetic protein 2%eukaryotic expression vector%chitosan%nanoparticle
目的:构建人骨形态发生蛋白(BMP)2的真核表达型载体,并利用其与壳聚糖制备纳米复合体。方法体外利用双酶切法将pMD18T-hBMP2-His质粒与pIRES2-EGFP真核表达载体连接,构建pIRES2-EGFP-hBMP2-His真核表达载体;采用5种不同相对分子质量及脱乙酰度的壳聚糖,通过去溶剂法在不同N/P比(壳聚糖中的胺基含量与质粒中磷酸基含量的摩尔比)情况下制备壳聚糖/pIRES2-EGFP-hBMP2-His纳米复合体。ZetaPALS电位及粒度分析仪检测纳米复合体的粒径大小、分布及Zeta电位,琼脂糖凝胶电泳分析及荧光分光法评定壳聚糖对pIRES2-EGFP-hBMP2-His纳米复合体的包裹情况,原子力显微镜观察粒径形貌。结果1)成功构建pIRES2-EGFP-hBMP2-His真核表达载体,并经酶切、测序证实;2)成功制备壳聚糖/pIRES2-EGFP-hBMP2-His纳米复合体,壳聚糖对pIRES2-EGFP-hBMP2-His质粒具有包裹作用;3)制备的壳聚糖/pIRES2-EGFP-hBMP2-His复合体呈球状,粒径为111.7~3214.2nm,Zeta电位为4.93~16.79mV。结论壳聚糖可与pIRES2-EGFP-hBMP2-His复合形成纳米微粒。
目的:構建人骨形態髮生蛋白(BMP)2的真覈錶達型載體,併利用其與殼聚糖製備納米複閤體。方法體外利用雙酶切法將pMD18T-hBMP2-His質粒與pIRES2-EGFP真覈錶達載體連接,構建pIRES2-EGFP-hBMP2-His真覈錶達載體;採用5種不同相對分子質量及脫乙酰度的殼聚糖,通過去溶劑法在不同N/P比(殼聚糖中的胺基含量與質粒中燐痠基含量的摩爾比)情況下製備殼聚糖/pIRES2-EGFP-hBMP2-His納米複閤體。ZetaPALS電位及粒度分析儀檢測納米複閤體的粒徑大小、分佈及Zeta電位,瓊脂糖凝膠電泳分析及熒光分光法評定殼聚糖對pIRES2-EGFP-hBMP2-His納米複閤體的包裹情況,原子力顯微鏡觀察粒徑形貌。結果1)成功構建pIRES2-EGFP-hBMP2-His真覈錶達載體,併經酶切、測序證實;2)成功製備殼聚糖/pIRES2-EGFP-hBMP2-His納米複閤體,殼聚糖對pIRES2-EGFP-hBMP2-His質粒具有包裹作用;3)製備的殼聚糖/pIRES2-EGFP-hBMP2-His複閤體呈毬狀,粒徑為111.7~3214.2nm,Zeta電位為4.93~16.79mV。結論殼聚糖可與pIRES2-EGFP-hBMP2-His複閤形成納米微粒。
목적:구건인골형태발생단백(BMP)2적진핵표체형재체,병이용기여각취당제비납미복합체。방법체외이용쌍매절법장pMD18T-hBMP2-His질립여pIRES2-EGFP진핵표체재체련접,구건pIRES2-EGFP-hBMP2-His진핵표체재체;채용5충불동상대분자질량급탈을선도적각취당,통과거용제법재불동N/P비(각취당중적알기함량여질립중린산기함량적마이비)정황하제비각취당/pIRES2-EGFP-hBMP2-His납미복합체。ZetaPALS전위급립도분석의검측납미복합체적립경대소、분포급Zeta전위,경지당응효전영분석급형광분광법평정각취당대pIRES2-EGFP-hBMP2-His납미복합체적포과정황,원자력현미경관찰립경형모。결과1)성공구건pIRES2-EGFP-hBMP2-His진핵표체재체,병경매절、측서증실;2)성공제비각취당/pIRES2-EGFP-hBMP2-His납미복합체,각취당대pIRES2-EGFP-hBMP2-His질립구유포과작용;3)제비적각취당/pIRES2-EGFP-hBMP2-His복합체정구상,립경위111.7~3214.2nm,Zeta전위위4.93~16.79mV。결론각취당가여pIRES2-EGFP-hBMP2-His복합형성납미미립。
Objective To clone and construct a eukaryotic expression vector of human bone morphogenetic protein (BMP) 2 and histidine in vitro and synthesize chitosan (CS)/pIRES2-EGFP-hBMP2-His nanoparticles. Methods pMD18T-hBMP2-His was digested by EcoRⅠand BamHⅠto obtain the hBMP2-His gene, which was inserted into pIRES2-EGFP to form pIRES2-EGFP-hBMP2-His. Afterward, CS, which exhibited five different molecular weights and deacetylation degrees, was complexed with pIRES2-EGFP-hBMP2-His to form CS/pIRES2-EGFP-hBMP2-His nanoparticles; in this procedure, a desolvent method was used at different N/P ratios (amino in CS to phospho in plasmid DNA). The gene-encapsulating ability of CS was evaluated by agarose gel electrophoresis and fluorescence spectrophotometry; size, distribution, and potential were analyzed using a ZetaPALS analyzer. The shape of the nanoparticles was observed under an atomic force microscope. Results 1) pIRES2-EGFP-hBMP2-His was constructed after the cloned hBMP2-His gene was confirmed by sequencing. 2) CS/pIRES2-EGFP-hBMP2-His nanoparticles were synthesized and pIRES2-EGFP-hBMP2-His was packaged by CS. 3) CS/pIRES2-EGFP-hBMP2-His nanoparticles were globular with an average size of 111.7 nm to 3 214.2 nm and an average zeta-potential of 4.93 mV to 16.79 mV. Conclusion CS/pIRES2-EGFP-hBMP2-His nanospheres are successfully syn-thesized.